![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
491kB |
Preview |
PDF (Supplementary Information)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
733kB |
| Item Type: | Letter |
|---|---|
| Title: | Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part phase Ib/II study |
| Creators Name: | Rambaldi, A., Iurlo, A., Vannucchi, A.M., Noble, R., von Bubnoff, N., Guarini, A., Martino, B., Pezzutto, A., Carli, G., De Muro, M., Luciani, S., McMullin, M.F., Cambier, N., Marolleau, J.P., Mesa, R.A., Tibes, R., Pancrazzi, A., Gesullo, F., Bettica, P., Manzoni, S. and Di Tollo, S. |
| Keywords: | Carbamates, Janus Kinase 2, Maximum Tolerated Dose, Mutation, Polycythemia Vera, Quality of Life |
| Source: | Leukemia |
| ISSN: | 0887-6924 |
| Publisher: | Nature Publishing Group |
| Volume: | 34 |
| Number: | 8 |
| Page Range: | 2234-2237 |
| Date: | August 2020 |
| Official Publication: | https://doi.org/10.1038/s41375-020-0735-y |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
